📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Uman Diagnostics

1.1 - Company Overview

Uman Diagnostics Logo

Uman Diagnostics

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of neurofilament light (Nf-L) antibodies and ELISA kits to advance the development of therapeutics and diagnostics for neurodegenerative conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Uman Diagnostics

CuraSen Therapeutics Logo

CuraSen Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for neurodegenerative diseases, developing orphan drugs including CST-103/CST-107, a combination therapy targeting cognitive symptoms and disease progression in Parkinson’s disease (Phase 2); CST-2032/CST-107 for Alzheimer’s disease with similar focus (Phase 2); and CST-3056, an alpha-1A adrenoceptor agonist in preclinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CuraSen Therapeutics company profile →
Seaport Therapeutics Logo

Seaport Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical solutions, including the Glyph platform, a proprietary lymphatic-targeting technology enabling and enhancing oral drug administration by bypassing first-pass metabolism and reducing hepatotoxicity, and SPT-300, an oral prodrug of allopregnanolone for treating mood and anxiety disorders, including anxious depression.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seaport Therapeutics company profile →
Carbylan Logo

Carbylan

HQ: United States Website
  • Description: Provider of products and services; specific offerings not available. Founded in 2004.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Carbylan company profile →
Iama Therapeutics Logo

Iama Therapeutics

HQ: Italy Website
  • Description: Provider of novel neuroscience therapeutics for pediatric brain disorders, advancing drug discovery to address unmet needs; lead candidate IAMA-6 is an orally administered small molecule targeting NKCC1-associated neuronal hyperexcitability, currently in Phase 1 clinical trials for autism and epilepsy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iama Therapeutics company profile →
Renovo Concepts Logo

Renovo Concepts

HQ: United States Website
  • Description: Provider of Mechanical Tissue Resuscitation (MTR™), a therapeutic modality using controlled vacuum to enhance microcirculation, improve cell survival, and reduce injury volume and secondary pathologies. Offerings include the Sub-atmospheric Pressure Pump™ (SaPP™) and a Gen 1 MTR™ brain application targeting traumatic brain injuries to decrease injury severity and improve recovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Renovo Concepts company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Uman Diagnostics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Uman Diagnostics

2.2 - Growth funds investing in similar companies to Uman Diagnostics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Uman Diagnostics

4.2 - Public trading comparable groups for Uman Diagnostics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Uman Diagnostics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Uman Diagnostics

What does Uman Diagnostics do?

Uman Diagnostics is a provider of neurofilament light (Nf-L) antibodies and ELISA kits to advance the development of therapeutics and diagnostics for neurodegenerative conditions.

Who are Uman Diagnostics's competitors?

Uman Diagnostics's competitors and similar companies include CuraSen Therapeutics, Seaport Therapeutics, Carbylan, Iama Therapeutics, and Renovo Concepts.

Where is Uman Diagnostics headquartered?

Uman Diagnostics is headquartered in Sweden.

How many employees does Uman Diagnostics have?

Uman Diagnostics has 1,000 employees 🔒.

When was Uman Diagnostics founded?

Uman Diagnostics was founded in 2010 🔒.

What sector and industry vertical is Uman Diagnostics in?

Uman Diagnostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Uman Diagnostics

Who are the top strategic acquirers in Uman Diagnostics's sector and industry

Top strategic M&A buyers and acquirers in Uman Diagnostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Uman Diagnostics?

Top strategic M&A buyers groups and sectors for Uman Diagnostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Uman Diagnostics's sector and industry vertical

Which are the top PE firms investing in Uman Diagnostics's sector and industry vertical?

Top PE firms investing in Uman Diagnostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Uman Diagnostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Uman Diagnostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Uman Diagnostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Uman Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Uman Diagnostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Uman Diagnostics?

The key public trading comparables and valuation benchmarks for Uman Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Uman Diagnostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Uman Diagnostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Uman Diagnostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Uman Diagnostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Uman Diagnostics's' sector and industry vertical?

Access recent funding rounds and capital raises in Uman Diagnostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Uman Diagnostics